Archive - July 2020
Roche’s Tecentriq combo scores FDA approval for melanoma
J&J’s COVID-19 vaccine generates positive pre-clinical results
NICE recommends Merck/Pfizer’s PD-L1 inhibitor Bavencio for kidney cancer
Gilead’s top-line slips 10% as demand for HIV/hepatitis C drugs drops
US expands scope of Janssen’s Stelara
UK firm starts research on skin patch for COVID vaccines
MHRA OKs Celltrion’s Phase I trial of COVID drug
EU regulators approve Novartis’ breast cancer combo